IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,824,484 | +14.6% | 238,635 | +3.6% | 0.26% | +20.0% |
| Q2 2023 | $9,447,609 | +44.9% | 230,261 | +26.2% | 0.22% | +14.6% |
| Q1 2023 | $6,519,870 | +24.0% | 182,425 | +31.1% | 0.19% | +29.7% |
| Q4 2022 | $5,256,866 | -17.9% | 139,181 | -3.9% | 0.15% | -21.3% |
| Q3 2022 | $6,404,000 | +44.5% | 144,795 | +21.0% | 0.19% | +51.6% |
| Q2 2022 | $4,431,000 | +1114.0% | 119,682 | +1115.3% | 0.12% | +1277.8% |
| Q1 2022 | $365,000 | +59.4% | 9,848 | +30.7% | 0.01% | +80.0% |
| Q4 2021 | $229,000 | -15.2% | 7,533 | -6.6% | 0.01% | -16.7% |
| Q3 2021 | $270,000 | -18.7% | 8,064 | -3.2% | 0.01% | -14.3% |
| Q2 2021 | $332,000 | -7.8% | 8,329 | +4.0% | 0.01% | 0.0% |
| Q1 2021 | $360,000 | +2.6% | 8,008 | +28.9% | 0.01% | -12.5% |
| Q4 2020 | $351,000 | -73.0% | 6,211 | -77.1% | 0.01% | -65.2% |
| Q4 2016 | $1,299,000 | -29.1% | 27,154 | -45.7% | 0.02% | -34.3% |
| Q3 2016 | $1,832,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |